Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study

BACKGROUND: Information is needed on the safety of adalimumab when used in pregnancy for the treatment of certain autoimmune diseases. METHODS AND FINDINGS: Between 2004 and 2016, the Organization of Teratology Information Specialists Research Center at the University of California San Diego conduct...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Chambers, Christina D., Johnson, Diana L., Xu, Ronghui, Luo, Yunjun, Lopez-Jimenez, Janina, Adam, Margaret P., Braddock, Stephen R., Robinson, Luther K., Vaux, Keith, Lyons Jones, Kenneth
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2019
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6799916/
https://ncbi.nlm.nih.gov/pubmed/31626646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0223603
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares